Antidepressants in Alzheimer's Disease: A Focus on the Role of Mirtazapine
- PMID: 34577630
- PMCID: PMC8467729
- DOI: 10.3390/ph14090930
Antidepressants in Alzheimer's Disease: A Focus on the Role of Mirtazapine
Abstract
Mirtazapine belongs to the category of antidepressants clinically used mainly in major depressive disorder but also used in obsessive-compulsive disorders, generalized anxiety, and sleep disturbances. This drug acts mainly by antagonizing the adrenergic α2, and the serotonergic 5-HT2 and 5-HT3 receptors. Neuropsychiatric symptoms, such as depression and agitation, are strongly associated with Alzheimer's disease, reducing the life quality of these patients. Thus, it is crucial to control depression in Alzheimer's patients. For this purpose, drugs such as mirtazapine are important in the control of anxiety, agitation, and other depressive symptoms in these patients. Indeed, despite some contradictory studies, evidence supports the role of mirtazapine in this regard. In this review, we will focus on depression in Alzheimer's disease, highlighting the role of mirtazapine in this context.
Keywords: Alzheimer’s disease; depression; mirtazapine.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression.CNS Drugs. 1996 May;5(5):389-402. doi: 10.2165/00023210-199605050-00007. CNS Drugs. 1996. PMID: 26071050
-
Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression.J Affect Disord. 1998 Dec;51(3):267-85. doi: 10.1016/s0165-0327(98)00224-9. J Affect Disord. 1998. PMID: 10333982 Review.
-
Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: a pilot study.Biol Psychiatry. 2000 Jul 1;48(1):75-8. doi: 10.1016/s0006-3223(00)00882-9. Biol Psychiatry. 2000. PMID: 10913511
-
A risk-benefit assessment of mirtazapine in the treatment of depression.Drug Saf. 1997 Oct;17(4):251-64. doi: 10.2165/00002018-199717040-00005. Drug Saf. 1997. PMID: 9352961 Review.
-
Mirtazapine: a review of its use in major depression.Drugs. 1999 Apr;57(4):607-31. doi: 10.2165/00003495-199957040-00010. Drugs. 1999. PMID: 10235695 Review.
Cited by
-
Exploring the Role of Drug Repurposing in Bridging the Hypoxia-Depression Connection.Membranes (Basel). 2023 Sep 17;13(9):800. doi: 10.3390/membranes13090800. Membranes (Basel). 2023. PMID: 37755222 Free PMC article.
-
Alzheimer's Disease: Exploring the Landscape of Cognitive Decline.ACS Chem Neurosci. 2024 Nov 6;15(21):3800-3827. doi: 10.1021/acschemneuro.4c00339. Epub 2024 Oct 11. ACS Chem Neurosci. 2024. PMID: 39392435 Free PMC article. Review.
-
The Aggravating Role of Failing Neuropeptide Networks in the Development of Sporadic Alzheimer's Disease.Int J Mol Sci. 2024 Dec 5;25(23):13086. doi: 10.3390/ijms252313086. Int J Mol Sci. 2024. PMID: 39684795 Free PMC article. Review.
-
Serotonin Type 3 Receptor Is Potentially Involved in Cellular Stress Induced by Hydrogen Peroxide.Life (Basel). 2022 Oct 19;12(10):1645. doi: 10.3390/life12101645. Life (Basel). 2022. PMID: 36295079 Free PMC article.
-
Pinus halepensis Essential Oil Ameliorates Aβ1-42-Induced Brain Injury by Diminishing Anxiety, Oxidative Stress, and Neuroinflammation in Rats.Biomedicines. 2022 Sep 16;10(9):2300. doi: 10.3390/biomedicines10092300. Biomedicines. 2022. PMID: 36140401 Free PMC article.
References
-
- Duthey B. Background paper 6.11: Alzheimer disease and other dementias. Public Health Approach Innov. 2013;6:1–74.
-
- Depression Alzheimer’s Association. [(accessed on 13 August 2021)]. Available online: https://www.alz.org/help-support/caregiving/stages-behaviors/depression.
-
- Agüera-Ortiz L., García-Ramos R., Grandas Pérez F.J., López-Álvarez J., Montes Rodríguez J.M., Olazarán Rodríguez F.J., Olivera Pueyo J., Pelegrin Valero C., Porta-Etessam J. Depression in Alzheimer’s Disease: A Delphi Consensus on Etiology, Risk Factors, and Clinical Management. Front. Psychiatry. 2021;12:141. doi: 10.3389/fpsyt.2021.638651. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources